raloxifene hydrochloride has been researched along with Femoral Fractures in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abrahamsen, B; Cohen-Solal, M; Eastell, R; Guañabens, N; Langdahl, B; McKenna, MJ; Ralston, SH; van de Laarschot, DM; Zillikens, MC | 1 |
| Amling, M; Beil, FT; Ignatius, A; Jeschke, A; Khadem, S; Marshall, RP; Pogoda, P; Spiro, AS | 1 |
| Mosekilde, L; Rejnmark, L; Schwartz, F; Vestergaard, P | 1 |
| Hongo, M; Kasukawa, Y; Miyakoshi, N; Sasaki, S; Shimada, Y | 1 |
| Chen, CH; Chen, JC; Cheng, YM; Fu, YC; Hsieh, CH; Huang, HT; Huang, PJ; Kang, L; Lin, SY | 1 |
| Begerow, B; Hinz, C; Minne, HW; Pfeifer, M; Pollähne, W | 1 |
| Roux, C | 1 |
| Barna, A; Bourgoin, M; Briot, K; Chapurlat, R; Christin-Maitre, S; Cortet, B; Costagliola, D; Diebolt, V; Dumarcet, N; Lacoin, F; Letombe, B; Nouyrigat, E; Oberlin, F; Orcel, P; Ravaud, P; Roux, C; Seret, P; Thomas, T; Veyries, ML; Vogel, JY; Yoldjian, I | 1 |
2 review(s) available for raloxifene hydrochloride and Femoral Fractures
| Article | Year |
|---|---|
Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.
Topics: Bone Density Conservation Agents; Denosumab; Diphosphonates; Europe; Femoral Fractures; Humans; Osteoporotic Fractures; Practice Patterns, Physicians'; Raloxifene Hydrochloride; Risk Assessment; Risk Factors; Societies, Medical; Teriparatide | 2020 |
[Drug treatment of postmenopausal osteoporosis. What's New in 2006].
Topics: Absorptiometry, Photon; Adult; Age Factors; Aged; Aged, 80 and over; Alendronate; Body Mass Index; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Female; Femoral Fractures; Follow-Up Studies; Fractures, Bone; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Practice Guidelines as Topic; Raloxifene Hydrochloride; Risk Factors; Spinal Fractures; Tablets; Teriparatide; Thiophenes; Time Factors | 2006 |
6 other study(ies) available for raloxifene hydrochloride and Femoral Fractures
| Article | Year |
|---|---|
The SERM raloxifene improves diaphyseal fracture healing in mice.
Topics: Animals; Diaphyses; Estrogens; Female; Femoral Fractures; Femur; Fracture Healing; Fractures, Bone; Humans; Mice; Mice, Inbred C57BL; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2013 |
Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Case-Control Studies; Denmark; Diphosphonates; Female; Femoral Fractures; Hip Fractures; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Raloxifene Hydrochloride; Risk Factors; Thiophenes | 2011 |
Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series.
Topics: Age Factors; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Plates; Diaphyses; Diphosphonates; Female; Femoral Fractures; Femur; Humans; Male; Osteoporosis; Radiography; Raloxifene Hydrochloride; Retrospective Studies | 2012 |
Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report.
Topics: Alendronate; Bone Density Conservation Agents; Female; Femoral Fractures; Fractures, Stress; Humans; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Teriparatide | 2012 |
[Weeks of pain, vertebral body fractures during sleep, invalidism. Save your osteoporosis patients from this fate].
Topics: Activities of Daily Living; Age Factors; Alendronate; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Disabled Persons; Etidronic Acid; Female; Femoral Fractures; Humans; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Pain; Raloxifene Hydrochloride; Risedronic Acid; Sex Factors; Spinal Fractures | 2002 |
[Osteoporosis priority: Reduce the number of fractures].
Topics: Absorptiometry, Photon; Age Factors; Aged; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Femoral Fractures; Fractures, Bone; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Prospective Studies; Raloxifene Hydrochloride; Risk Factors; Spinal Fractures; Teriparatide; Thiophenes; Time Factors | 2006 |